January 15, 2010, Newsletter Issue #54: What role has the FDA approval process played in the Vioxx problems?
Tip of the Week
The director for Science and Medicine at the Office of Drug Safety, David Graham, delivered a scathing assessment of FDA drug approval policy. He blamed the 55,000 or more Vioxx deaths on the FDA's decision in 1999 to approve Merck & Co.'s sale of the drug, despite data that suggested the arthritis medication was linked to increased risks of heart attack and stroke. "Unless the FDA establishes an independent division to monitor the safety of drugs once they're on the market, Graham said, more Vioxx-like disasters are likely."
About LifeTips
Now one of the top on-line publishers in the world, LifeTips offers tips to millions of monthly visitors. Our mission mission is to make your life smarter, better, faster and wiser. Expert writers earn dough for what they know. And exclusive sponsors in each niche topic help us make-it-all happen.
